2010 Rate Card

Article

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Subscribe Now!
Recent Videos
Another drop in the presbyopia bucket: Dr Bloomenstein shares his excitement for the FDA approval of Vizz
1 expert in this video
1 expert in this video
Related Content
Tubulointerstitial nephritis and uveitis- A multidisciplinary approach to diagnosing a rare disease - Image credit: ©Halfpoint—stock.adobe.com

Tubulointerstitial nephritis and uveitis: A multidisciplinary approach to diagnosing a rare disease

Lynda Charters
August 11th 2025
Article
The Neural Network: Exploring The Role of Neuromodulation in Dry Eye Disease Management

The Neural Network: Exploring The Role of Neuromodulation in Dry Eye Disease Management

August 11th 2025
Podcast
SAHARA trial demonstrates sustained TearCare benefits for evaporative dry eye - Image credit: ©Crystal—stock.adobe.com

SAHARA trial demonstrates sustained TearCare benefits for evaporative dry eye

Abigail Lewis, intern
August 11th 2025
Article
Neurotrophic Keratitis: Multidisciplinary Approaches to Enhance Patient Outcomes

Neurotrophic Keratitis: Multidisciplinary Approaches to Enhance Patient Outcomes

August 11th 2025
Podcast
Parental lag time is primary reason for delayed diagnosis and treatment of retinoblastoma - Image credit: ©Graphicroyalty—stock.adobe.com

Parental lag time is primary reason for delayed diagnosis and treatment of retinoblastoma

Lynda Charters
August 11th 2025
Article
TearCare System (Photo courtesy Sight Sciences)

Sight Sciences releases cost-utility analysis comparing TearCare and cyclosporine 0.05% in dry eye

Martin David Harp, Editor, Ophthalmology Times
August 11th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.